查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1643503

心臟病学人工智慧的全球市场

Artificial Intelligence in Cardiology
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 172 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，心臟病学人工智慧全球市场预计将达到 43 亿美元

2024 年全球心臟病学人工智慧市场规模估计为 13 亿美元，预计到 2030 年将达到 43 亿美元，2024-2030 年分析期内的复合年增长率为 22.7%。心臟病学 AI 硬体是该报告分析的细分市场之一，预计到分析期结束时复合年增长率为 22.3%，达到 17 亿美元。预计分析期内心臟病学 AI 服务部门的复合年增长率为 19.9%。

美国市场规模估计为 3.289 亿美元，中国市场预计复合年增长率为 21.6%

预计2024年美国心臟病学人工智慧市场规模将达3.289亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 6.541 亿美元，2024-2030 年分析期间的复合年增长率为 21.6%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 20.7% 和 19.6%。在欧洲，预计德国的复合年增长率约为 15.7%。

全球心臟病学人工智慧市场—主要趋势和驱动因素摘要

人工智慧将如何改变心臟的诊断和治疗？

人工智慧 (AI) 正在透过实现精准诊断、预测分析和个人化治疗策略彻底改变心臟病学。心臟病学的传统诊断方法通常依赖对影像、心电图 (ECG) 和其他临床资料的手动解释，这既耗时又容易发生变化。人工智慧透过以惊人的速度和精度分析大型资料集，识别人类医生可能忽视的模式和异常来解决这些挑战。

例如，搭载人工智慧的影像诊断系统将提高冠状动脉疾病、心律不整、心臟衰竭等疾病的诊断准确性。机器学习演算法处理超音波心动图、 电脑断层扫描和 MRI，以提供有关心臟功能和结构的详细见解，从而实现更快、更准确的诊断。此外，人工智慧主导的心电图分析系统可以即时检测心律不整和其他电异常，确保及时干预，从而改善结果。

在治疗计画中，AI会分析患者的遗传、病历和生活方式等特定因素，以达到个人化治疗。预测模型评估心血管事件的风险并指导医生调整预防措施和治疗计划。这些进步凸显了人工智慧在提高循环系统护理品质和效率方面的变革作用。

推动人工智慧在心臟病学领域应用的因素有哪些？

全球心血管疾病（CVD）负担日益加重是循环系统领域采用人工智慧的关键驱动因素。心血管疾病仍然是全球最大的死亡原因，需要创新的解决方案来加强预防、诊断和治疗。人工智慧工具将使医疗保健专业人员能够及早识别高风险患者并实施预防措施，从而降低这些疾病的盛行率和严重程度。

高品质临床资料的日益普及是另一个重要因素。穿戴式装置、远端监控系统和电子健康记录等资料收集技术的进步产生了大量心血管资料。人工智慧系统分析这些资料以发现可操作的见解，实现即时监控和决策。这种能力在偏远和资源受限的环境中尤其有价值，因为这些地区无法获得专门的心臟护理。

此外，远端医疗平台和人工智慧的整合正在增强心臟病学服务的可及性。主导工具将透过分析患者资料并向医生提供诊断建议来支援远端咨询。这种整合使得医疗保健更加便利和高效，特别是在医疗服务不足的地区。这些趋势凸显了人工智慧作为现代心臟病护理关键组成部分的日益依赖。

人工智慧能否改善患者治疗效果并优化心血管照护？

人工智慧在改善患者治疗效果和优化心血管护理方面发挥关键作用。透过实现更快、更准确的诊断，人工智慧可以降低併发症的风险并改善治疗结果。预测分析工具可以识别心臟病和中风等疾病风险的患者，从而帮助医疗保健提供者实施预防措施以降低死亡率。

在外科手术和介入性心臟病学领域，人工智慧正在协助规划和执行。人工智慧引导的机器人辅助系统将提高支架置入和瓣膜置换等手术的精确度，最大限度地降低风险并改善恢復结果。此外，人工智慧主导的临床决策支援系统将协助医生选择最合适的治疗方法，确保为个别患者提供最佳护理。

人工智慧在远端患者监护中的作用也有助于改善治疗效果。这款穿戴式装置配备人工智慧演算法，可追踪心率和血压等生命体征，以检测病情恶化的早期预警讯号。这种即时监控使患者能够有效地管理自己的病情，并允许医生在必要时迅速介入。这些进步凸显了人工智慧改变心血管照护和改善全球数百万患者生活的潜力。

是什么推动了心臟病学市场人工智慧的成长？

心臟病学市场人工智慧的成长由几个关键因素推动，反映了其在解决心血管健康挑战方面的变革潜力。心血管疾病的发生率不断上升以及对先进诊断和治疗解决方案的需求是主要的成长动力。人工智慧工具提高了循环系统工作流程的准确性和效率，以满足日益增长的优质照护需求。

人工智慧演算法的技术进步，加上穿戴式装置和远端监控系统的广泛使用，推动了该领域的持续创新。这些工具产生即时资料，由人工智慧系统进行分析，提供可操作的见解和个人化的护理建议。对人工智慧医疗设备的监管支援和对医疗技术的投资增加进一步推动了市场扩张。

消费者对便利、高效的医疗保健的期望也促进了人工智慧在心臟病学领域的应用。患者越来越多地寻求能够主动进行健康管理的工具，而人工智慧解决方案则透过提供预测分析和远端监控功能来满足这一需求。这些因素加上正在进行的研究和开发，正在推动心臟病学人工智慧市场的快速成长，并使其成为未来心血管护理进步的关键。

部分

组件（硬体组件、服务组件、软体组件）、医疗状况（缺血性心臟疾病/CAD 医疗状况、心律不整医疗状况、心臟衰竭医疗状况、其他医疗状况）、应用程式（诊断应用程式、药物研发应用程式、预测应用程式、其他应用程式）

受访企业范例（共36家）

  • CardiAI, Inc.
  • Cleerly, Inc.
  • IDOVEN
  • Koninklijke Philips NV
  • RSIP Vision
  • Tempus AI, Inc.
  • UltraSight
  • Ultromics Limited
  • Vista.ai
  • Viz

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP29253

Global Artificial Intelligence in Cardiology Market to Reach US$4.3 Billion by 2030

The global market for Artificial Intelligence in Cardiology estimated at US$1.3 Billion in the year 2024, is expected to reach US$4.3 Billion by 2030, growing at a CAGR of 22.7% over the analysis period 2024-2030. Cardiology AI Hardware, one of the segments analyzed in the report, is expected to record a 22.3% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Cardiology AI Services segment is estimated at 19.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$328.9 Million While China is Forecast to Grow at 21.6% CAGR

The Artificial Intelligence in Cardiology market in the U.S. is estimated at US$328.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$654.1 Million by the year 2030 trailing a CAGR of 21.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 20.7% and 19.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.7% CAGR.

Global Artificial Intelligence in Cardiology Market - Key Trends & Drivers Summarized

How Is AI Transforming Cardiology Diagnostics and Treatment?

Artificial Intelligence (AI) is revolutionizing cardiology by enabling precise diagnostics, predictive analytics, and personalized treatment strategies. Traditional diagnostic methods in cardiology often rely on manual interpretation of imaging, electrocardiograms (ECGs), and other clinical data, which can be time-consuming and prone to variability. AI addresses these challenges by analyzing large datasets with unparalleled speed and accuracy, identifying patterns and abnormalities that might be overlooked by human practitioners.

For example, AI-powered imaging systems enhance the accuracy of diagnosing conditions such as coronary artery disease, arrhythmias, and heart failure. Machine learning algorithms process echocardiograms, CT scans, and MRIs to deliver detailed insights into cardiac function and structure, enabling earlier and more accurate diagnosis. Additionally, AI-driven ECG analysis systems detect arrhythmias and other electrical anomalies in real time, improving outcomes by ensuring timely intervention.

In treatment planning, AI is enabling personalized care by analyzing patient-specific factors such as genetics, medical history, and lifestyle. Predictive models assess the risk of cardiovascular events, guiding physicians in tailoring preventive measures and treatment plans. These advancements underscore AI’s transformative role in improving the quality and efficiency of cardiology care.

What Drives the Adoption of AI in Cardiology?

The rising global burden of cardiovascular diseases (CVDs) is a significant driver of AI adoption in cardiology. CVDs remain the leading cause of death worldwide, necessitating innovative solutions to enhance prevention, diagnosis, and treatment. AI-powered tools provide healthcare professionals with the ability to identify high-risk patients early and implement preventive measures, reducing the prevalence and severity of these conditions.

The increasing availability of high-quality clinical data is another critical factor. Advances in data collection technologies, such as wearable devices, remote monitoring systems, and electronic health records, generate vast amounts of cardiovascular data. AI systems analyze this data to uncover actionable insights, enabling real-time monitoring and decision-making. These capabilities are particularly valuable in remote and resource-constrained settings, where access to specialized cardiology care may be limited.

Moreover, the integration of AI with telemedicine platforms is enhancing access to cardiology services. AI-driven tools support remote consultations by analyzing patient data and providing physicians with diagnostic recommendations. This integration is improving care accessibility and efficiency, especially in underserved regions. These trends highlight the growing reliance on AI as a critical component of modern cardiology practice.

Can AI Improve Patient Outcomes and Optimize Cardiovascular Care?

AI is playing a pivotal role in improving patient outcomes and optimizing the delivery of cardiovascular care. By enabling earlier and more accurate diagnosis, AI reduces the risk of complications and enhances the effectiveness of treatments. Predictive analytics tools identify patients at risk of conditions such as heart attacks and strokes, allowing healthcare providers to implement preventive measures and reduce mortality rates.

In surgical and interventional cardiology, AI is assisting in planning and execution. Robotic-assisted systems guided by AI improve the precision of procedures such as stent placement and valve replacement, minimizing risks and improving recovery outcomes. Additionally, AI-driven clinical decision support systems aid physicians in selecting the most appropriate therapies, ensuring optimal care for individual patients.

AI’s role in remote patient monitoring is also contributing to better outcomes. Wearable devices equipped with AI algorithms track vital signs such as heart rate and blood pressure, detecting early warning signs of deterioration. This real-time monitoring empowers patients to manage their conditions effectively while enabling physicians to intervene promptly when necessary. These advancements underscore AI’s potential to transform cardiovascular care and improve the lives of millions of patients worldwide.

What’s Driving the Growth of the AI in Cardiology Market?

The growth in the Artificial Intelligence in Cardiology market is driven by several key factors, reflecting its transformative potential in addressing cardiovascular health challenges. The increasing prevalence of cardiovascular diseases and the associated demand for advanced diagnostic and therapeutic solutions are significant growth drivers. AI-powered tools enhance the accuracy and efficiency of cardiology workflows, meeting the growing need for high-quality care.

Technological advancements in AI algorithms, coupled with the proliferation of wearable devices and remote monitoring systems, are enabling continuous innovation in the field. These tools generate real-time data, which AI systems analyze to deliver actionable insights and personalized care recommendations. Regulatory support for AI-driven medical devices and growing investments in healthcare technology are further fueling market expansion.

Consumer expectations for accessible and efficient healthcare are also contributing to the adoption of AI in cardiology. Patients are increasingly seeking tools that enable proactive health management, and AI solutions address this demand by offering predictive analytics and remote monitoring capabilities. These factors, combined with ongoing research and development, are propelling the rapid growth of the AI in Cardiology market, positioning it as a cornerstone of future advancements in cardiovascular care.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence in Cardiology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Hardware Component, Services Component, Software Component); Medical Condition (Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition, Other Medical Conditions); Application (Diagnosis Application, Drug Discovery Application, Prediction Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • CardiAI, Inc.
  • Cleerly, Inc.
  • IDOVEN
  • Koninklijke Philips NV
  • RSIP Vision
  • Tempus AI, Inc.
  • UltraSight
  • Ultromics Limited
  • Vista.ai
  • Viz

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Artificial Intelligence in Cardiology - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • AI-Driven Cardiac Imaging Solutions Propel Growth in Early Diagnosis of Heart Conditions
    • Predictive Analytics in AI Strengthens Market for Risk Assessment in Cardiology
    • AI-Powered Wearable Devices Expand Opportunities in Remote Cardiac Monitoring
    • Advancements in AI-Enhanced ECG Analysis Drive Adoption in Diagnostic Centers
    • AI Algorithms for Detecting Heart Irregularities Strengthen Case for Faster Interventions
    • Integration of AI in Telecardiology Sets the Stage for Remote Healthcare Solutions
    • Demand for AI in Cardiac Rehabilitation Programs Spurs Adoption in Post-Care
    • AI Integration in Robotics for Cardiac Surgery Drives Demand in Minimally Invasive Techniques
    • Real-Time AI Insights for Blood Pressure Monitoring Propel Consumer Device Markets
    • AI in Remote Pacemaker Monitoring Highlights Consumer Health Potential
    • AI-Enhanced Cardiology Workflow Automation Drives Efficiency Across Hospitals
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence in Cardiology Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence in Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Hardware Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Services Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Software Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Prediction Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Prediction Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Diagnosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Drug Discovery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Drug Discovery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Ischemic Heart Disease / CAD Medical Condition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Ischemic Heart Disease / CAD Medical Condition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiac Arrhythmias Medical Condition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Cardiac Arrhythmias Medical Condition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Heart Failure Medical Condition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Heart Failure Medical Condition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other Medical Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other Medical Conditions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030

IV. COMPETITION